Beijing-based firms Immunochina Pharmaceuticals and Cell Store have announced a strategic partnership aimed at bolstering the industrialization and commercialization of cell therapies in China. The financial details of the collaboration have not been disclosed.
Innovative Cryopreservation Technology from Cell Store
Cell Store is an innovative biotech company that specializes in “controlled cryopreservation” technology for biological samples. Their product solutions encompass the cryopreservation of human-derived cells, reproductive cells in assisted reproduction, and biological tissues for preservation and fidelity. This technology is critical for maintaining the safety and efficacy of cell therapies throughout the production and transportation processes.
Leveraging Expertise for Drug Development
Immunochina Pharmaceuticals, a specialist in gene therapy, is recognized for its next-generation chimeric antigen receptor (CAR)-T technology. Under the terms of the partnership, Cell Store will provide its unique controlled freezing storage technology to ensure the safety and effectiveness of cell therapy drugs. In turn, Immunochina will leverage its extensive experience in the development of cell therapy drugs to accelerate the research and development process, aiming to create more efficient and safe biological therapy products.-Fineline Info & Tech
